3JUFFE AS,RAVKILDE J,ROBERTS R,et al.It's Time for a change to a troponin standard[J].Circulation,2000,102(11):1216-1220.
4ANTMAN EM,ANBE DT,ARMSTRONG PW,et al.ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction[J].J Am Coil Cardiol,2004,44(3):671-719.
5GENSINI GG.A more meaningful scoring system for determining the severity of coronary disease[J].Am J Cardiol,1983,51(3):606.
6THEROUX P,FUSTER V.Acute coronary syndromes:unstable angina and non-Q-wave myocardial infarction[J].Circulation,1998,97(12):1195-1206.
7SPENCER FA,SANTOPINTO JJ,GORE JM,et al.Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events[GRACE])[J].AmJ Cardiol,2002,90(10):1056-1061.
8The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342(3):145-153.
9MARSCHNER IC,COLQUHOUN D,SIMES RJ,et al.Long-term risk stratification for survivors of acute coronary syndromes.Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study:LIPID study investigators[J].J Am Coll Cardiol,2001,38(1):56-63.
10CANNON CP,WEINTRAUB WS,DEMOPOULOS LA,et al.Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱ b/Ⅲa inhibitor tirofiban[J].N Engl J Med,2001,344(25):1879-1887.
